This role will drive the design and implementation of advanced biofabricated tissue models, microphysiological systems, and cellular platforms to accelerate hit identification, lead discovery, lead optimization for small molecules and biologics, and in vitro safety assessment
Ensure compliance with all internal and external regulatory and safety standards
Ability to thrive in a fast-paced, innovation-driven environment
In addition to supporting assay cell culture needs for HTS and lead optimization, this team will develop cutting-edge technologies including CRISPR-engineered cell lines, iPSC-derived models, organoids, complex co-culture systems, and primary immune cell platforms to enable high-throughput compound screening and mechanistic studies Developing Others, Drug Discovery Development, Inclusive Leadership, Industry Analysis, Leadership, Molecular Diagnostics, Operational Excellence, Pharmaceutical Microbiology, Product Knowledge, Project Reporting, Scientific Research, Strategic Thinking, Team Management